Bellevue Group’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-149,113
Closed -$9.52M 152
2025
Q1
$9.52M Sell
149,113
-22,204
-13% -$1.42M 0.21% 77
2024
Q4
$20.8M Sell
171,317
-173,031
-50% -$21M 0.4% 61
2024
Q3
$43M Buy
344,348
+92,027
+36% +$11.5M 0.7% 39
2024
Q2
$39.9M Buy
252,321
+800
+0.3% +$126K 0.65% 44
2024
Q1
$32.6M Buy
251,521
+14,235
+6% +$1.84M 0.5% 61
2023
Q4
$22.9M Sell
237,286
-4,466
-2% -$431K 0.35% 71
2023
Q3
$29.3M Buy
241,752
+41,532
+21% +$5.03M 0.47% 63
2023
Q2
$22.9M Sell
200,220
-446,394
-69% -$51.1M 0.33% 70
2023
Q1
$89.1M Sell
646,614
-46,595
-7% -$6.42M 1.29% 20
2022
Q4
$89.8M Sell
693,209
-62,689
-8% -$8.12M 1.19% 24
2022
Q3
$83.6M Sell
755,898
-383,557
-34% -$42.4M 1.2% 27
2022
Q2
$85.4M Sell
1,139,455
-11,704
-1% -$877K 1.21% 24
2022
Q1
$89.9M Buy
1,151,159
+324,418
+39% +$25.3M 1.04% 33
2021
Q4
$74.4M Buy
826,741
+257,573
+45% +$23.2M 0.77% 44
2021
Q3
$52.6M Buy
+569,168
New +$52.6M 0.53% 61
2021
Q2
Sell
-20,300
Closed -$1.51M 222
2021
Q1
$1.51M Hold
20,300
0.02% 149
2020
Q4
$3.46M Hold
20,300
0.04% 132
2020
Q3
$2.85M Hold
20,300
0.04% 138
2020
Q2
$3.26M Buy
20,300
+300
+2% +$48.1K 0.05% 128
2020
Q1
$1.96M Buy
20,000
+4,500
+29% +$440K 0.04% 129
2019
Q4
$2M Buy
+15,500
New +$2M 0.03% 131
2019
Q2
Sell
-9,100
Closed -$1.09M 213
2019
Q1
$1.09M Sell
9,100
-3,600
-28% -$429K 0.06% 125
2018
Q4
$1.39M Sell
12,700
-400
-3% -$43.7K 0.09% 104
2018
Q3
$2.12M Buy
+13,100
New +$2.12M 0.13% 103